Serving the Pacific Rim Bio-Tech Industry

At Dragon Bio-Consultants we think of ourselves as “artisans” — the term used before mass manufacturing/globalization to apply to people who made things or provided services with a distinctive touch in which they took personal pride. We at Dragon Bio-Consultants consider ourselves artisans and we bring something extra to our jobs that ultimately benefit our clients. Our ultimate aim is to expand our client’s “perimeter of potential”.

William Porter, Jr., Managing Director and Co-Founder

As a business executive, lobbyist, educator, and consultant, William has over 35 years experience in the biopharmaceutical industry, education, project management, government relations, and the U.S. auto industry. Since 1996, William has lived in Bangkok and Hong Kong working in the biobusiness sector, international education, and project management.

William graduated from Michigan State University with a Bachelor of Science degree in Physical and Earth Science, with teaching certification from the Michigan Department of Education. He also received his Master’s degree in Education from Michigan State University in 1977.

R. Stephen Porter, Pharm.D., FCP, MRCP, Chief Science Officer

Dr. R. Stephen Porter is:

  • President, CEO and Chairman of the VDDI Pharmaceuticals (VDDI); 2000
  • Chief Scientific Officer of Dragon Bio-Consulting, LTD.; 2010
  • Chief Scientific Advisor and Officer to MPI Research and continues to serve as an advisor to MPI.
  • Helped establish Chinese Preclinical CRO JV between MPI Research Medicilon Shanghai
  • President of Pharmacotherapy Consultants, LLC, Brentwood, TN  since 2005
  • Founder and Medical adviser to Pioneer Technologies, LLC a wound care company based in Nashville.  2007
  • Founder and Partner Vault Associates; LLC  a Medical Device development and marketing company Nashville, TN 2008
  • Dr. Porter was formerly the Executive Director of Medical Affairs for Therapeutic Antibodies Inc.; launched DigiFab®, CroFab®
  • Associate Director of Cardiovascular and Drug Metabolism in its Medical Research Division and helped launch Sonata® and Ziac®.
  • Director of Cardiovascular Pharmacology at the Likoff Cardiovascular Institute within the Hahnemann School of Medicine in Philadelphia.
  • Faculty at University of East Carolina Medical School and University North Carolina Medical School and School of Pharmacy.
  • Dr. Porter received his doctorate in pharmacy from the University of Michigan, where he also completed his undergraduate degree and a Clinical Pharmacy residency.
  • Membership in the American Society for Clinical Pharmacology and Therapeutics, the American College of Clinical Pharmacy, Royal Society of Medicine, and Fellowship in the American College of Clinical Pharmacology.